Previous studies have shown that complete hepatic p53 inactivation results in liver steatosis, inflammation, and/or ER stress.[26, 27, 28] Therefore, we used shRNA to partially reduce hepatic p53 expression. Here, TP53 is linked to fatty liver disease.